Limacorporate S.p.a
31
7
10
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.7%
3 terminated/withdrawn out of 31 trials
76.9%
-9.6% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (31)
H-34 DELTA Revision Cup
Role: lead
Physica TT Tibial Plate Follow up Study
Role: lead
H-35 CL TRAUMA Cemented Femoral Stem
Role: lead
Hip Arthroplasty With Logica Mirror Femoral Stem
Role: lead
CoCrMo LOCK Bipolar Femoral Heads FU
Role: lead
Cephalic Femoral Heads Follow Up
Role: lead
Randomized MINIMA Stem with DELTA TT or DELTA ST-C
Role: lead
Physica System KR Vs Physica System CR (K-20)
Role: lead
Hip Arthroplasty With SL Cementless
Role: lead
Multigen Plus CCK and AMF TT Cones Follow Up Study
Role: lead
Physica CR and Physica PS Clinical Trial
Role: lead
Clinical Study Evaluating the Outcomes of a New Knee System with a Physiological Rollback Mechanism
Role: lead
Multigen Plus H Study and AMF TT Cones
Role: lead
H-29 DELTA Multihole TT Study.
Role: lead
SMR Stemless Shoulder Arthroplasty Clinical Study
Role: lead
Physica TT Tibial Plate Prospective Study
Role: lead
PRIMA EU Retrospective & Prospective
Role: lead
SMR Stemless Reverse Vs SMR Reverse Shoulder System
Role: lead
Minima Clinical Study
Role: lead
Revision LR Femoral Stem for Hip Replacement
Role: lead